Frequency of mutations in rpoB and codons 315 and 463 of katG in rifampin- and/or isoniazid-resistant Mycobacterium tuberculosis isolates from Northeast Mexico

Microbial Drug Resistance

Volumn 9, Issue 1, 2003, Pages 33-38

  Viader Salvadó, José María ^a   Luna Aguirre, Claudia Maribel ^b   Reyes Ruiz, Jorge Mauricio ^b   Valdez Leal, Ramón ^c   De Los Angeles Del Bosque Moncayo, Mariá ^c   Tijerina Menchaca, Rolando ^a   Guerrero Olazarán, Martha ^a  

^a UNIVERSIDAD AUTÓNOMA DE NUEVO LEÓN   (Mexico)

^b Medicina UANL   (Mexico)

^c Laboratorio Estatal de Salud Pública de los Servicios de Salud de Nuevo León   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; ISONIAZID; KATG PROTEIN; RIFAMPICIN; RNA POLYMERASE BETA SUBUNIT; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL GENETICS; BACTERIAL MUTATION; BACTERIAL STRAIN; BACTERIUM ISOLATE; CODON; GENE IDENTIFICATION; GENETIC MARKER; MEXICO; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SCREENING;

BACTERIA (MICROORGANISMS); MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS;

EID: 0037354109     PISSN: 10766294     EISSN: None     Source Type: Journal    
DOI: 10.1089/107662903764736328     Document Type: Article

References (29)

1. Altschul, S.F., W. Gish, W. Miller, E.W. Myers, and D.J. Lipman. 1990. Basic local alignment search tool. J. Mol. Biol. 215:403-410.
2. Belisle, J.T., and M.G. Sonnenberg. 1998. Isolation of genomic DNA from mycobacteria. Methods Mol Biol. 101:31-44.
3. Butler, W.R., M.M. Floyd, V. Silcox, G. Cage, E. Desmond, P.S. Duffey, L.S. Guthertz, W. Gross, K.C. Jost, L.S. Ramos, L. Thibert, and N. Warren. 1996. Steering Committee, HPLC Users Group (ed.), Standardized method for HPLC identification of mycobacteria. Washington, D.C., U.S. Department of Health and Human Services.
4. Butler, W.R., M.M. Floyd, V. Silcox, G. Cage, E. Desmond, P.S. Duffey, L.S. Guthertz, W. Gross, K.C. Jost, L.S. Ramos, L. Thibert, and N. Warren. 1999. Steering Committee, HPLC Users Group (ed.), Mycolic acid pattern standards for HPLC identification of mycobacteria. Washington, D.C., U.S. Department of Health and Human Services.
5. Butler, W.R., and L.S. Guthertz. 2001. Mycolic acid analysis by high-performance liquid chromatography for identification of Mycobacterium species. Clin. Microbiol. Rev. 14:701-726.
6. Canetti, G., S. Frosman, J.H. Grosset, P. Hauduroy, M. Langerova, H.T. Mahler, G. Meissner, D.A. Mitchison, and L. Sula. 1963. Mycobacteria: laboratory methods for testing drug sensitivity and resistance. Bull. WHO 29:565-578.
7. Cooksey, R.C., G.P. Morlock, S. Glickman, and J.T. Crawford. 1997. Evaluation of a line probe assay kit for characterization of rpoB mutations in rifampin-resistant Mycobacterium tuberculosis isolates from New York City. J. Clin. Microbiol. 35:1281-1283.
8. Dobner, P., S. Rusch-Gerdes, G. Bretzel, K. Feldmann, M. Rifai, T. Loscher, and H. Rinder. 1997. Usefulness of Mycobacterium tuberculosis genomic mutations in the genes katG and inhA for the prediction of isoniazid resistance. Int. J. Tuberc. Lung Dis. 1:365-369.
9. Engels, W.R. 1993. Contributing software to the internet: the Amplify program. Trends Biochem. Sci. 18:448-450.
10. Garza-González, E., M. Guerrero-Olazarán, R. Tijerina-Menchaca, and J.M. Viader-Salvadó. 1998. Identification of mycobacteria by mycolic acid pattern. Arch. Med. Res. 29:303-306.
11. Haas, W.H., K. Schilke, J. Brand, B. Amthor, K. Weyer, P.B. Fourie, G. Bretzel, V. Stticht-Groh, and H.J. Bremer. 1997. Molecular analysis of katG gene mutations in strains of Mycobacterium tuberculosis complex from Africa. Antimicrob. Agents. Chemother. 41:1601-1603.
12. Kapur, V., L.L. Li, S. Iordanescu, M.R. Hamrick, A. Wanger, B.N. Kreiswirth, and J.M. Musser. 1994. Characterization by automated DNA sequencing of mutations in the gene (rpoB) encoding the RNA polymerase b subunit in rifampin-resistant Mycobacterium tuberculosis strains from New York City. J. Clin. Microbiol. 32:1095-1098.
13. Kent, P.T., and G.P. Kubica. 1985. Public health mycobacteriology: a guide for the level III laboratory, U.S. Department of Health and Human Services publication no. 86-8230. Washington, D.C., U.S. Department of Health and Human Services.
14. Kiepiela, P., K.S. Bishop, A.N. Smith, L. Roux, and D.F. York. 2000. Genomic mutations in the katG, inhA and aphC genes are useful for the prediction of isoniazid resistance in Mycobacterium tuberculosis isolates from Kwazulu Natal, South Africa. Tuber. Lung. Dis. 80:47-56.
15. Marck, C. 1988. DNA Strider: a C program for the fast analysis of DNA and protein sequences on the Apple Macintosh family of computers. Nucleic Acids Res. 16:1829-1836.
16. Matsiota-Bernard, P., G. Vrioni, and E. Marinis. 1998. Characterization of rpoB mutations in rifampin-resistant clinical Mycobacterium tuberculosis isolates from Greece. J. Clin. Microbiol. 36:20-23.
17. Musser, J.M., V. Kapur, D.L. Williams, B.N. Kreiswirth, D.V. Soolingen, and J. Embden. 1996. Characterization of the Catalase-peroxidase gGene (katG) and inhA locus in isoniazid-resistant and susceptible strains of Mycobacterium tuberculosis by automated DNA sequencing: restricted array of mutations associated with drug resistance. J. Infect. Dis. 173:196-202.
18. Nachamkin, I., C. Kang, and M.P. Weinstein 1997. Detection of resistance to isoniazid, rifampin, and streptomycin in clinical isolates of Mycobacterium tuberculosis by molecular methods. Clin. Infect. Dis. 24:894-900.
19. National Committee for Clinical Laboratory Standards. 1995. Antimycobacterial susceptibility testing for Mycobacterium tuberculosis. Proposed standard M24-T. National Committee for Clinical Laboratory Standards, Villanova, PA.
20. Rossau, R., H. Traore, H. Beenhouwer, W. Mijs, G. Jannes, P. Rijk, and F. Portaels. 1997. Evaluation of the INNO-LiPA Rif. TB assay, a reverse hybridization assay for the simultaneous detection of Mycobacterium tuberculosis complex and its resistance to rifampin. Antimicrob. Agents Chemother. 41:2093-2098.
21. Rozen, S., and H.J. Skaletsky. 1996. Primer3. Code available at http:// www-genome.wi.mit.edu/genome_software/other/primer3.html.
22. Shim, T.S., C.G. Yoo, S.K. Han, Y.S. Shim, and Y.W. Kim. 1997. Isoniazid resistance and the point mutation of codon 463 of katG gene of Mycobacterium tuberculosis. J. Korean Med. Sci. 12:92-98.
23. Sreevatsan, S., J.B. Bookout, F.M. Ringpis, S.L. Mogazeh, B.N. Kreiswirth, R.R. Pottathil, and R.R. Barathur. 1998. Comparative evaluation of cleavase fragment length polymorphism with PCR-SSCP and PCR-RFLP to detect antimicrobial agent resistance in Mycobacterium tuberculosis. Mol. Diagn. 3:81-91.
24. Telenti, A. 1997. Genetics of drug resistance in tuberculosis. Clin. Chest. Med. 18:55-64.
25. Telenti, A., P. Imboden, F. Marchesi, D. Lowrie, S. Cole, M.J. Colston, L. Matter, K. Schopfer, and T. Bodmer. 1993. Detection of rifampicin-resistance in Mycobacterium tuberculosis. Lancet 341:647-650.
26. Telenti, A., and D.H. Persing. 1996. Novel strategies for the detection of drug resistance in Mycobacterium tuberculosis. Res. Microbiol. 147:73-79.
27. Viader-Salvadó, J.M., E. Garza-González, R. Valdez-Leal, M.A. del Bosque-Moncayo, R. Tijerina-Menchaca, and M. Guerrero-Olazarán. 2001. Mycolic acid index susceptibility method for Mycobacterium tuberculosis. J. Clin. Microbiol. 39:2642-2645.
28. Viader-Salvadó, J.M., M. Guerrero-Olazarán, E. Garza-González, and R. Tijerina-Menchaca. 2000. Drug susceptibility of Mycobacterium tuberculosis through the mycolic acid index. Methods. Mol. Med. 48:13-19.
29. Williams, D.L., L. Spring, L. Collins, L.P. Miller, L.B. Heifets, P.R.J. Gangadharam, and T.P. Gillis. 1998. Contribution of rpoB mutations to development of rifampicin cross-resistance in Mycobacterium tuberculosis. Antimicob. Agents Chemother. 42:1853-1857.